PHAXIAM Therapeutics S.A.
PHXM
NASDAQ Capital Market3.10
USD
-0.17
- -
Total Valuation
PHAXIAM Therapeutics S.A. carries a market capitalization of 19.86M, placing it among publicly traded companies globally.
| Market Cap | 19.86M |
| Enterprise Value | N/A |
Stock Price Statistics
PHAXIAM Therapeutics S.A.'s stock has declined approximately -62.91866% over the past 52 weeks. The 50-day moving average sits at 3.88, while the 200-day moving average is 5.17.
| Beta (5Y) | N/A |
| 52-Week Price Change | -62.91866% |
| 50-Day Moving Average | 3.88 |
| 200-Day Moving Average | 5.17 |
| Average Volume (20 Days) | N/A |
Stock Splits
PHAXIAM Therapeutics S.A.'s most recent stock split took place on September 20, 2023 with a 10:1 split ratio.
| Last Split Date | 9/20/2023 |
| Split Ratio | 10:1 |